Root Admin Guide Posted July 4, 2016 Root Admin Report Share Posted July 4, 2016 According to an article by Fiscal Standard, "Paratek Pharmaceuticals, Inc. (Partake), formerly Transcept Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry." The article then mentions the following: "Sarecycline is designed for use in the treatment of acne and rosacea." This article further states, "The Company’s sarecycline is a Phase III antibacterial product candidate and was previously known as WC3035." Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now